Cefotaxime is a prescription medicine. The sections below reproduce one FDA label for it, named under "Label". Products in other forms, strengths or from other makers have their own labels, which can differ.
On the FDA shortage list — 4 products are unavailable or in limited supply. Which forms
- Type
- Prescription only (Rx)
- Taken
- Intramuscular, Intravenous
- Label
- SteriMax Inc., revised June 15, 2026 · full label on DailyMed
- Generic
- No · details
Is there a generic Cefotaxime?
Not currently. Generic versions were approved in the past, but all of them are listed as discontinued in FDA records.
Brand-name versions
- Claforan Sterimax, approved 1981
- Claforan In Dextrose 5% In Plastic Container Sterimax, approved 1985 Discontinued
- Cefotaxime And Dextrose 2.4% In Plastic Container B Braun, approved 2004 Discontinued
Source: Drugs@FDA (via openFDA), checked October 29, 2026. Marketing status is what companies report to the FDA; whether a pharmacy stocks a product, and what your insurance covers, can differ.
Dosage:
we do not reproduce dosing instructions. The right dose depends on the person and the condition and is set by the prescriber or pharmacist. Dosage section of the full label.
Cefotaxime in the news
We have not covered this medicine yet. Latest news
Shortage status
| Product | Availability | Expected supply / notes |
|---|---|---|
| Cefotaxime Sodium, Powder, for Solution, 2 g (NDC 0143-9933-25) Hikma Pharmaceuticals USA, Inc. |
Unavailable | Estimated recovery: TBD In shortage · October 14, 2026 |
| Cefotaxime Sodium, Powder, for Solution, 10 g (NDC 0143-9935-01) Hikma Pharmaceuticals USA, Inc. |
Unavailable | Estimated recovery: TBD In shortage · October 14, 2026 |
| Cefotaxime Sodium, Powder, for Solution, 500 mg (NDC 0143-9930-10) Hikma Pharmaceuticals USA, Inc. |
Unavailable | Estimated recovery: TBD In shortage · October 14, 2026 |
| Cefotaxime Sodium, Powder, for Solution, 1 g (NDC 0143-9931-25) Hikma Pharmaceuticals USA, Inc. |
Unavailable | Estimated recovery: TBD In shortage · October 14, 2026 |
| Cefotaxime Sodium, Powder, for Solution, 2 g (NDC 21586-012-02) SteriMax, Inc. |
Available | — In shortage · June 15, 2026 |
| Cefotaxime Sodium, Powder, for Solution, 1 g (NDC 21586-011-02) SteriMax, Inc. |
Available | — In shortage · June 15, 2026 |
Recalls
No recalls matched to this medicine in FDA enforcement reports from the last 3 years (or older ones still open). Search all recalls
Get alerts for Cefotaxime
We will email you if the FDA reports a recall, if its shortage status changes, or when we publish news about it — at most one email a day. No account needed.
Source: FDA structured product labeling, retrieved through openFDA. Label text is shown as published by the FDA, without editing; long sections are shortened, marked […]. openFDA data are not validated for clinical use — always check the current label and ask a doctor or pharmacist about your own treatment. Set ID 8efe3bd0-c43a-2bd6-e053-2a95a90a92fa.